📹 You can watch the interviews by @vjhemonc.bsky.social and Hematological Oncology recorded after her presentation here: buff.ly/46MXfGA
#TheMaxFoundation #GlobalHealth #HealthcareAccess #CancerInnovation
#TheMaxFoundation #GlobalHealth #HealthcareAccess #CancerInnovation
Interviews with VJHemOnc
At the 13th Annual SOHO Meeting in Houston (Sept 3–6, 2025), Pat Garcia-Gonzalez, CEO of The Max Foundation presented data from our access to CML treatment program, including a treatment free…
buff.ly
September 12, 2025 at 7:19 PM
📹 You can watch the interviews by @vjhemonc.bsky.social and Hematological Oncology recorded after her presentation here: buff.ly/46MXfGA
#TheMaxFoundation #GlobalHealth #HealthcareAccess #CancerInnovation
#TheMaxFoundation #GlobalHealth #HealthcareAccess #CancerInnovation
Her presentation highlighted that TFR can be a safe and feasible option for patients in low- and middle-income countries, offering hope for a future where lifelong treatment may not be the only path.
💬 What do you think—could treatment-free remission become a game-changer for CML care globally?
💬 What do you think—could treatment-free remission become a game-changer for CML care globally?
Interviews with VJHemOnc
At the 13th Annual SOHO Meeting in Houston (Sept 3–6, 2025), Pat Garcia-Gonzalez, CEO of The Max Foundation presented data from our access to CML treatment program, including a treatment free…
buff.ly
September 12, 2025 at 7:19 PM
Her presentation highlighted that TFR can be a safe and feasible option for patients in low- and middle-income countries, offering hope for a future where lifelong treatment may not be the only path.
💬 What do you think—could treatment-free remission become a game-changer for CML care globally?
💬 What do you think—could treatment-free remission become a game-changer for CML care globally?
Last week at the 13th annual @societyofhemonc.bsky.social meeting, our CEO @patggmax.bsky.social shared insights into our chronic myeloid leukemia (CML) access program and unveiled promising results from a pilot program exploring treatment-free remission (TFR) in resource-limited settings.
Interviews with VJHemOnc
At the 13th Annual SOHO Meeting in Houston (Sept 3–6, 2025), Pat Garcia-Gonzalez, CEO of The Max Foundation presented data from our access to CML treatment program, including a treatment free…
buff.ly
September 12, 2025 at 7:18 PM
Last week at the 13th annual @societyofhemonc.bsky.social meeting, our CEO @patggmax.bsky.social shared insights into our chronic myeloid leukemia (CML) access program and unveiled promising results from a pilot program exploring treatment-free remission (TFR) in resource-limited settings.
Feed: "MashupMD"
By: Mashup MD on Wednesday, September 3, 2025
By: Mashup MD on Wednesday, September 3, 2025
VJHemOnc – The video journal of hematological oncology
Up-to-date medical news aggregated from trusted medical associations, journals, physicians and news outlets from around the world.
www.mashupmd.com
September 3, 2025 at 1:57 PM
Feed: "MashupMD"
By: Mashup MD on Wednesday, September 3, 2025
By: Mashup MD on Wednesday, September 3, 2025
#EBMT26 post-congress episode you don't want to miss:
🎙️ Advances in stem cell transplantation from EBMT 2026: managing GvHD, donor selection & evolving clinical strategies
Listen today ➡️ vjhemonc.com/podcast/adva...
#GvHD #HCT #celltherapy #podcast
🎙️ Advances in stem cell transplantation from EBMT 2026: managing GvHD, donor selection & evolving clinical strategies
Listen today ➡️ vjhemonc.com/podcast/adva...
#GvHD #HCT #celltherapy #podcast
Advances in stem cell transplantation from EBMT 2026: managing GvHD, donor selection & evolving clinical strategies
This VJHemOnc podcast highlights key advances in hematopoietic stem cell transplantation from the EBMT 2026 Annual Meeting, spanning graft-versus-host disease...
vjhemonc.com
April 27, 2026 at 10:52 AM
#EBMT26 post-congress episode you don't want to miss:
🎙️ Advances in stem cell transplantation from EBMT 2026: managing GvHD, donor selection & evolving clinical strategies
Listen today ➡️ vjhemonc.com/podcast/adva...
#GvHD #HCT #celltherapy #podcast
🎙️ Advances in stem cell transplantation from EBMT 2026: managing GvHD, donor selection & evolving clinical strategies
Listen today ➡️ vjhemonc.com/podcast/adva...
#GvHD #HCT #celltherapy #podcast
Dr. Curtis Lachowiez discusses the influence of #AML differentiation state on outcomes of patients treated with frontline hypomethylating agents plus venetoclax at #ASH24.
Watch (via @vjhemonc.bsky.social):
Watch (via @vjhemonc.bsky.social):
Influence of AML differentiation state on outcomes of patients treated with frontline HMA + ven
YouTube video by VJHemOnc – Video Journal of Hematology & HemOnc
www.youtube.com
January 8, 2025 at 4:21 PM
Dr. Curtis Lachowiez discusses the influence of #AML differentiation state on outcomes of patients treated with frontline hypomethylating agents plus venetoclax at #ASH24.
Watch (via @vjhemonc.bsky.social):
Watch (via @vjhemonc.bsky.social):
At #ASH2025, Prof. Florent Malard shared Phase III ARES results with #VJHEMONC, highlighting Xervyteg® (MaaT013) in aGvHD: 62% GI response, 64% ORR and 54% 1-year OS.
👉 Full interview: www.vjhemonc.com/video/xm1_uw...
@ash.hematology.org @vjhemonc.bsky.social
👉 Full interview: www.vjhemonc.com/video/xm1_uw...
@ash.hematology.org @vjhemonc.bsky.social
Results of ARES: allogeneic microbiotherapy for ruxolitinib-refractory GvHD with GI involvement
Florent Malard, MD, PhD, Saint-Antoine Hospital and Sorbonne University, Paris, France, discusses the Phase III ARES trial (NCT04769895) of MaaT013,...
www.vjhemonc.com
December 19, 2025 at 3:14 PM
At #ASH2025, Prof. Florent Malard shared Phase III ARES results with #VJHEMONC, highlighting Xervyteg® (MaaT013) in aGvHD: 62% GI response, 64% ORR and 54% 1-year OS.
👉 Full interview: www.vjhemonc.com/video/xm1_uw...
@ash.hematology.org @vjhemonc.bsky.social
👉 Full interview: www.vjhemonc.com/video/xm1_uw...
@ash.hematology.org @vjhemonc.bsky.social
🎙️ The VJHemOnc Podcast has been voted one of the Top 10 Hematology Podcasts of the Year by Million Podcasts 🏆
Stay ahead with the latest news, trial updates & debates in #Lymphoma, #Myeloma, #Leukemia & more.
EXPLORE NOW 👉 buff.ly/gv47n7q
#HemOnc #MMSM #Leusm #LYMsm #ImmunoOnc #BloodSky #HemeSky
Stay ahead with the latest news, trial updates & debates in #Lymphoma, #Myeloma, #Leukemia & more.
EXPLORE NOW 👉 buff.ly/gv47n7q
#HemOnc #MMSM #Leusm #LYMsm #ImmunoOnc #BloodSky #HemeSky
September 23, 2025 at 1:02 PM
We at VJHemOnc know that data from trials are not always directly applicable to clinical practice or easily digested.📄
That's why we created the Community Focus channel: to help bridge the gap between research & care, and support evidence-based practice! 🏥
Explore here:
🔗 buff.ly/Dk0QZny
#MedSky
That's why we created the Community Focus channel: to help bridge the gap between research & care, and support evidence-based practice! 🏥
Explore here:
🔗 buff.ly/Dk0QZny
#MedSky
September 18, 2025 at 9:00 AM
We at VJHemOnc know that data from trials are not always directly applicable to clinical practice or easily digested.📄
That's why we created the Community Focus channel: to help bridge the gap between research & care, and support evidence-based practice! 🏥
Explore here:
🔗 buff.ly/Dk0QZny
#MedSky
That's why we created the Community Focus channel: to help bridge the gap between research & care, and support evidence-based practice! 🏥
Explore here:
🔗 buff.ly/Dk0QZny
#MedSky
We've had a wonderful first day at #EHA2025! Thank you to Amer Zeidan of @yalecancer.bsky.social, who shared interesting insights into the use of immune checkpoint inhibition in MDS, the KOMET-017 trial, & more!
Stay tuned 👉VJHemOnc.com!
#MDSsm #HemOnc #LeuSM #AMLsm #BloodSky #CTSM #TrialUpdate
Stay tuned 👉VJHemOnc.com!
#MDSsm #HemOnc #LeuSM #AMLsm #BloodSky #CTSM #TrialUpdate
June 12, 2025 at 3:30 PM
We've had a wonderful first day at #EHA2025! Thank you to Amer Zeidan of @yalecancer.bsky.social, who shared interesting insights into the use of immune checkpoint inhibition in MDS, the KOMET-017 trial, & more!
Stay tuned 👉VJHemOnc.com!
#MDSsm #HemOnc #LeuSM #AMLsm #BloodSky #CTSM #TrialUpdate
Stay tuned 👉VJHemOnc.com!
#MDSsm #HemOnc #LeuSM #AMLsm #BloodSky #CTSM #TrialUpdate
Thank you to the lovely Lucia Masarova of @mdanderson.bsky.social for interviewing with us at #EHA2025! We heard about the prognostic impact of peripheral blasts in PV, INCA33989 (a first-in-class mAb targeting CALR) & many more exciting MPN updates!
Stay tuned for our interviews🎥🩸
#MPNsm #HemOnc
Stay tuned for our interviews🎥🩸
#MPNsm #HemOnc
June 12, 2025 at 12:05 PM
Thank you to the lovely Lucia Masarova of @mdanderson.bsky.social for interviewing with us at #EHA2025! We heard about the prognostic impact of peripheral blasts in PV, INCA33989 (a first-in-class mAb targeting CALR) & many more exciting MPN updates!
Stay tuned for our interviews🎥🩸
#MPNsm #HemOnc
Stay tuned for our interviews🎥🩸
#MPNsm #HemOnc
Catch up on the latest breakthroughs in #HemOnc with our expert-led Post-#EHA2025 Highlights webinars 💻📍
🔗 REGISTER 👉 vjhemonc.com/event/post-e...
#VJHemOnc
🔗 REGISTER 👉 vjhemonc.com/event/post-e...
#VJHemOnc
May 29, 2025 at 9:17 AM
Catch up on the latest breakthroughs in #HemOnc with our expert-led Post-#EHA2025 Highlights webinars 💻📍
🔗 REGISTER 👉 vjhemonc.com/event/post-e...
#VJHemOnc
🔗 REGISTER 👉 vjhemonc.com/event/post-e...
#VJHemOnc
🔊 Exciting news!
We now have a Community Focus channel on VJHemOnc aimed at providing the latest updates to community physicians & HCPs to support evidence-based practice.🩸
Interested in finding out more?
🔗 Click here to explore now: buff.ly/vBS1UYe
#HemOnc #MedSky #HemeSky #BloodSky
We now have a Community Focus channel on VJHemOnc aimed at providing the latest updates to community physicians & HCPs to support evidence-based practice.🩸
Interested in finding out more?
🔗 Click here to explore now: buff.ly/vBS1UYe
#HemOnc #MedSky #HemeSky #BloodSky
April 23, 2025 at 2:04 PM
🔊 Exciting news!
We now have a Community Focus channel on VJHemOnc aimed at providing the latest updates to community physicians & HCPs to support evidence-based practice.🩸
Interested in finding out more?
🔗 Click here to explore now: buff.ly/vBS1UYe
#HemOnc #MedSky #HemeSky #BloodSky
We now have a Community Focus channel on VJHemOnc aimed at providing the latest updates to community physicians & HCPs to support evidence-based practice.🩸
Interested in finding out more?
🔗 Click here to explore now: buff.ly/vBS1UYe
#HemOnc #MedSky #HemeSky #BloodSky
Next month we will be hosting the Miami #Myeloma #MRD Meeting 2025!🩸 📣
🗓️ 11 April
📍Online
Chair: Ola Landgren, MD, PhD
REGISTER here & take a look at the agenda 👉 buff.ly/41pls7x...
#VJHemOnc #Hematologynews #MMsm
@imfmyeloma.bsky.social @healthtreeorg.bsky.social @themmrf.bsky.social
🗓️ 11 April
📍Online
Chair: Ola Landgren, MD, PhD
REGISTER here & take a look at the agenda 👉 buff.ly/41pls7x...
#VJHemOnc #Hematologynews #MMsm
@imfmyeloma.bsky.social @healthtreeorg.bsky.social @themmrf.bsky.social
March 18, 2025 at 9:29 AM
Next month we will be hosting the Miami #Myeloma #MRD Meeting 2025!🩸 📣
🗓️ 11 April
📍Online
Chair: Ola Landgren, MD, PhD
REGISTER here & take a look at the agenda 👉 buff.ly/41pls7x...
#VJHemOnc #Hematologynews #MMsm
@imfmyeloma.bsky.social @healthtreeorg.bsky.social @themmrf.bsky.social
🗓️ 11 April
📍Online
Chair: Ola Landgren, MD, PhD
REGISTER here & take a look at the agenda 👉 buff.ly/41pls7x...
#VJHemOnc #Hematologynews #MMsm
@imfmyeloma.bsky.social @healthtreeorg.bsky.social @themmrf.bsky.social
VJHemOnc is currently in Munich at ISALXIX, interviewing experts for the latest updates in acute leukemias.
Follow us for live updates, and stay tuned on VJHemOnc.com for exclusive interviews coming soon!🎥
#Leukemia #ALL #AML
Follow us for live updates, and stay tuned on VJHemOnc.com for exclusive interviews coming soon!🎥
#Leukemia #ALL #AML
March 17, 2025 at 9:59 AM
VJHemOnc is currently in Munich at ISALXIX, interviewing experts for the latest updates in acute leukemias.
Follow us for live updates, and stay tuned on VJHemOnc.com for exclusive interviews coming soon!🎥
#Leukemia #ALL #AML
Follow us for live updates, and stay tuned on VJHemOnc.com for exclusive interviews coming soon!🎥
#Leukemia #ALL #AML
Soon we will be hosting the Miami #Myeloma #MRD Meeting 2025!🩸 📣
🗓️ 11 April
📍Online
Chair: Ola Landgren, MD, PhD
REGISTER here & take a look at the agenda 👉 us06web.zoom.us/webinar/regi...
#VJHemOnc #Hematologynews #MMsm @imfmyeloma.bsky.social @healthtreeorg.bsky.social @themmrf.bsky.social
🗓️ 11 April
📍Online
Chair: Ola Landgren, MD, PhD
REGISTER here & take a look at the agenda 👉 us06web.zoom.us/webinar/regi...
#VJHemOnc #Hematologynews #MMsm @imfmyeloma.bsky.social @healthtreeorg.bsky.social @themmrf.bsky.social
February 21, 2025 at 11:07 AM
Soon we will be hosting the Miami #Myeloma #MRD Meeting 2025!🩸 📣
🗓️ 11 April
📍Online
Chair: Ola Landgren, MD, PhD
REGISTER here & take a look at the agenda 👉 us06web.zoom.us/webinar/regi...
#VJHemOnc #Hematologynews #MMsm @imfmyeloma.bsky.social @healthtreeorg.bsky.social @themmrf.bsky.social
🗓️ 11 April
📍Online
Chair: Ola Landgren, MD, PhD
REGISTER here & take a look at the agenda 👉 us06web.zoom.us/webinar/regi...
#VJHemOnc #Hematologynews #MMsm @imfmyeloma.bsky.social @healthtreeorg.bsky.social @themmrf.bsky.social
#WorldCancerDay 2025🌍
At VJHemOnc, we are dedicated to supporting healthcare professionals by providing #independent, open-access #medicalnews & #education for the online #healthcareprofessional community🎥🩸
🌐 Discover our disease channels 👉 https://buff.ly/3PKc0oP
At VJHemOnc, we are dedicated to supporting healthcare professionals by providing #independent, open-access #medicalnews & #education for the online #healthcareprofessional community🎥🩸
🌐 Discover our disease channels 👉 https://buff.ly/3PKc0oP
February 4, 2025 at 9:29 AM
#WorldCancerDay 2025🌍
At VJHemOnc, we are dedicated to supporting healthcare professionals by providing #independent, open-access #medicalnews & #education for the online #healthcareprofessional community🎥🩸
🌐 Discover our disease channels 👉 https://buff.ly/3PKc0oP
At VJHemOnc, we are dedicated to supporting healthcare professionals by providing #independent, open-access #medicalnews & #education for the online #healthcareprofessional community🎥🩸
🌐 Discover our disease channels 👉 https://buff.ly/3PKc0oP
Join us for our Post-ASH 2024 Highlights starting NEXT WEEK!🔬🩸
Presentations & discussions on selected abstracts from
#ASH24
Unpack groundbreaking findings & join the conversation with leading #HemOnc experts 🔦
REGISTER NOW 👉 buff.ly/4hMI6Nr
#Hematologynews #MedicalEducation #VJHemOnc
Presentations & discussions on selected abstracts from
#ASH24
Unpack groundbreaking findings & join the conversation with leading #HemOnc experts 🔦
REGISTER NOW 👉 buff.ly/4hMI6Nr
#Hematologynews #MedicalEducation #VJHemOnc
January 15, 2025 at 12:43 PM
Join us for our Post-ASH 2024 Highlights starting NEXT WEEK!🔬🩸
Presentations & discussions on selected abstracts from
#ASH24
Unpack groundbreaking findings & join the conversation with leading #HemOnc experts 🔦
REGISTER NOW 👉 buff.ly/4hMI6Nr
#Hematologynews #MedicalEducation #VJHemOnc
Presentations & discussions on selected abstracts from
#ASH24
Unpack groundbreaking findings & join the conversation with leading #HemOnc experts 🔦
REGISTER NOW 👉 buff.ly/4hMI6Nr
#Hematologynews #MedicalEducation #VJHemOnc
Happy Holidays from VJHemOnc! 🎄☃️ 🧣
As 2024 comes to an end, we want to thank all of you for being a part of our journey this year 🧡
Wishing you a joyful holiday season and a happy, healthy New Year! ✨
Here’s to an even bigger and better 2025! 🌟
#VJHemOnc #HappyHolidays
As 2024 comes to an end, we want to thank all of you for being a part of our journey this year 🧡
Wishing you a joyful holiday season and a happy, healthy New Year! ✨
Here’s to an even bigger and better 2025! 🌟
#VJHemOnc #HappyHolidays
December 24, 2024 at 2:00 PM
Happy Holidays from VJHemOnc! 🎄☃️ 🧣
As 2024 comes to an end, we want to thank all of you for being a part of our journey this year 🧡
Wishing you a joyful holiday season and a happy, healthy New Year! ✨
Here’s to an even bigger and better 2025! 🌟
#VJHemOnc #HappyHolidays
As 2024 comes to an end, we want to thank all of you for being a part of our journey this year 🧡
Wishing you a joyful holiday season and a happy, healthy New Year! ✨
Here’s to an even bigger and better 2025! 🌟
#VJHemOnc #HappyHolidays
Check out our recent feature article, which covers the late-breaking abstracts presented at #ASH24!
Don't worry if you missed out - we've got you covered!📖🩸
👉https://buff.ly/3Bpau84
#LymSM #HemOnc #SickleCellDisease #MPNsm @ash-hematology.bsky.social #MedSky #BloodSky #HemeSky #HemeOnc
Don't worry if you missed out - we've got you covered!📖🩸
👉https://buff.ly/3Bpau84
#LymSM #HemOnc #SickleCellDisease #MPNsm @ash-hematology.bsky.social #MedSky #BloodSky #HemeSky #HemeOnc
ASH 2024 press briefing rundown: treating not-so-benign hematology conditions | VJHemOnc
VJHemOnc is thrilled to bring you the latest updates from the 64th American Society of Hematology (ASH) Annual Meeting and Exposition, held in New Orleans, LA, from 10 - 13 December 2022, with a…
buff.ly
December 23, 2024 at 10:00 AM
Check out our recent feature article, which covers the late-breaking abstracts presented at #ASH24!
Don't worry if you missed out - we've got you covered!📖🩸
👉https://buff.ly/3Bpau84
#LymSM #HemOnc #SickleCellDisease #MPNsm @ash-hematology.bsky.social #MedSky #BloodSky #HemeSky #HemeOnc
Don't worry if you missed out - we've got you covered!📖🩸
👉https://buff.ly/3Bpau84
#LymSM #HemOnc #SickleCellDisease #MPNsm @ash-hematology.bsky.social #MedSky #BloodSky #HemeSky #HemeOnc
Join us for our Post-ASH 2024 Highlights!🔬🩸
Presentations & discussions on selected abstracts from #ASH24
Unpack groundbreaking findings & join the conversation with leading #HemOnc experts 🔦
REGISTER NOW 👉 https://buff.ly/4hMI6Nr
#Hematologynews #MedicalEducation #VJHemOnc
Presentations & discussions on selected abstracts from #ASH24
Unpack groundbreaking findings & join the conversation with leading #HemOnc experts 🔦
REGISTER NOW 👉 https://buff.ly/4hMI6Nr
#Hematologynews #MedicalEducation #VJHemOnc
December 19, 2024 at 1:27 PM
Join us for our Post-ASH 2024 Highlights!🔬🩸
Presentations & discussions on selected abstracts from #ASH24
Unpack groundbreaking findings & join the conversation with leading #HemOnc experts 🔦
REGISTER NOW 👉 https://buff.ly/4hMI6Nr
#Hematologynews #MedicalEducation #VJHemOnc
Presentations & discussions on selected abstracts from #ASH24
Unpack groundbreaking findings & join the conversation with leading #HemOnc experts 🔦
REGISTER NOW 👉 https://buff.ly/4hMI6Nr
#Hematologynews #MedicalEducation #VJHemOnc
We’re thrilled to see so many of you discovered the VJHemOnc Podcast in 2024! 🎧🩸✨
For those who haven’t tuned in yet, check out our latest episodes & SUBSCRIBE👉 www.vjhemonc.com/podcasts/
#SpotifyWrapped #MedicalEducation #Hematologynews #HemOncPodcast
For those who haven’t tuned in yet, check out our latest episodes & SUBSCRIBE👉 www.vjhemonc.com/podcasts/
#SpotifyWrapped #MedicalEducation #Hematologynews #HemOncPodcast
December 18, 2024 at 12:05 PM
We’re thrilled to see so many of you discovered the VJHemOnc Podcast in 2024! 🎧🩸✨
For those who haven’t tuned in yet, check out our latest episodes & SUBSCRIBE👉 www.vjhemonc.com/podcasts/
#SpotifyWrapped #MedicalEducation #Hematologynews #HemOncPodcast
For those who haven’t tuned in yet, check out our latest episodes & SUBSCRIBE👉 www.vjhemonc.com/podcasts/
#SpotifyWrapped #MedicalEducation #Hematologynews #HemOncPodcast
#CARTCell therapy is now being used to treat several hematological malignancies, but what is its efficacy in Richter's transformation?🤔💉
Jennifer Woyach shares the findings of a study investigating this:
👉 https://buff.ly/3OFYX7k👈
#ImmunoOnc #CLLsm #HemOnc
Jennifer Woyach shares the findings of a study investigating this:
👉 https://buff.ly/3OFYX7k👈
#ImmunoOnc #CLLsm #HemOnc
The efficacy of CAR T-cell therapy in Richter’s transformation | VJHemOnc
Jennifer Woyach, MD, The Ohio State University, Columbus, OH, discusses a study investigating the efficacy of CAR T-cell therapy in...
buff.ly
December 11, 2024 at 3:00 PM
#CARTCell therapy is now being used to treat several hematological malignancies, but what is its efficacy in Richter's transformation?🤔💉
Jennifer Woyach shares the findings of a study investigating this:
👉 https://buff.ly/3OFYX7k👈
#ImmunoOnc #CLLsm #HemOnc
Jennifer Woyach shares the findings of a study investigating this:
👉 https://buff.ly/3OFYX7k👈
#ImmunoOnc #CLLsm #HemOnc
Watch as @ireneghobrial.bsky.social @danafarber.bsky.social dives into groundbreaking insights from longitudinal single-cell studies & #teclistamab outcomes at #ASH24 🎥
Don't miss this #VJHemOnc interview 👉 tinyurl.com/3u7dkrhn
@ash-hematology.bsky.social #MultipleMyeloma #MMsm
Don't miss this #VJHemOnc interview 👉 tinyurl.com/3u7dkrhn
@ash-hematology.bsky.social #MultipleMyeloma #MMsm
December 9, 2024 at 8:04 PM
Watch as @ireneghobrial.bsky.social @danafarber.bsky.social dives into groundbreaking insights from longitudinal single-cell studies & #teclistamab outcomes at #ASH24 🎥
Don't miss this #VJHemOnc interview 👉 tinyurl.com/3u7dkrhn
@ash-hematology.bsky.social #MultipleMyeloma #MMsm
Don't miss this #VJHemOnc interview 👉 tinyurl.com/3u7dkrhn
@ash-hematology.bsky.social #MultipleMyeloma #MMsm